Updated:2024-12-11 03:13 Views:82
A Tilray employee walks past cannabis plants at their greenhouses at the company’s headquarters in Cantanhede, Coimbra district on November 27, 2024. Agence France-Presse
SERPA, Portugal — “We should be the new El Dorado of medical cannabis production,” said agronomist Jose Martins as dozens of workers harvested marijuana in bright sunshine at a farm in southeastern Portugal.
The country is fast becoming a European hub for medical cannabis, with its warm temperate subtropical climate — often compared to California’s — making it an ideal place to grow the plant.
Article continues after this advertisement“No other country in Europe has better environmental conditions,” Martins told AFP at the plantation, which is surrounded by razor wire and infrared cameras.
FEATURED STORIES GLOBALNATION Taiwan says China carrying out huge maritime deployment GLOBALNATION Pogos changing tactics to avoid crackdown – officials GLOBALNATION UnitedHealthcare CEO ‘killer’: Brainy, 'normal guy'READ: More than half of Europeans support cannabis legalization—report
Set in hills near Serpa dotted with olive trees and cork oaks, the 5.4-hectare (13.3-acre) farm owned by the Portuguese pharmaceutical company FAI Therapeutic produces around 30 tonnes of cannabis flowers a year.
Article continues after this advertisementThey set up two years ago after a flood of foreign cannabis producers were drawn to Portugal because of its favourable climate and legislation.
Article continues after this advertisementMore than 60 companies are currently authorised to grow, produce or distribute medical cannabis products there, with 170 more having applied for permission.
Article continues after this advertisementPortugal exported some 12 tonnes of cannabis-based medical products last year, mainly to Germany — Europe’s largest market — as well as to Poland, Spain and Australia, according to the national drugs agency, Inframed.
High standardsBut the industry has even higher ambitions.
Article continues after this advertisement“Portugal is clearly at the forefront of European countries producing cannabis for medical use,” said Jose Tempero, the medical director at Tilray, a Canadian multinational that set up a cannabis farm near the central town of Cantanhede in 2019, straight after Portugal legalized marijuana-based medicines.
READ: Going to pot: Legalized cannabis around the world
The farm has its own labs and processing and packaging sites, with its cannabis oil selling as far afield as Latin America.
The Portuguese boom is fueled by growing global demand for medical cannabis for chronic pain, the side effects of cancer therapy, some forms of epilepsy and other ailments.
Around 50 nations have so far approved the use of cannabis-based medicines, and that number is expected to rise.
The global medical cannabis market is expected to grow to over $65 billion by 2030 from $16.6 billion last year, according consulting firm Grand View Research.
“There is a huge demand from patients,” said Bernard Babel, the head of German cannabis pharmaceutical firm Avextra, which set up part of its business in Portugal.
Portugal’s rising importance in the emerging industry down to more than its sunny climate, however.
Babel said it has “very good regulatory framework” thanks to its 2019 legislation which sets well-defined quality standards, he added.
‘Growing acceptance’Pedro Ferraz da Costa, CEO of the Iberfar Group, the parent firm of the Serpa farm, said these regulations reassure international customers “that the products leaving the country offer safety guarantees”.
While Portugal may be at the forefront of medical cannabis production in Europe, patients in the country complain they have difficulty obtaining the drugs since many doctors are still reluctant to prescribe them and their cost is not fully covered by state healthcare.
“There is a lack of information” within the medical profession in this “very conservative” country, said Lara Silva, whose six-year-old daughter suffers from a serious form of epilepsy that has hampered her motor and cognitive development.
When she decided to treat her daughter with CBD, a derivative of cannabis two years ago, she said she had to order it from Spain.
Subscribe to our daily newsletter
Tilray’s Tempero said medical marijuana still suffers from a certain “stigma” but he sees “a growing acceptance of cannabis beyond its recreational use”.ph365
READ NEXT Teves will again appeal court decision granting his extraditio... China’s shows of force against Taiwan EDITORS' PICK Meralco’s electricity rate up by 10¢/kWh in December Inspiring generosity in Manila: Dear SV reaches out to forgotten residents SEC chief leads 2024 The Outstanding Filipino awardees Apl.de.Ap teams up with 3,000 Filipino kids for new Christmas song Kaspersky to public: Use strong, unique passwords to repel hackers Tropical cyclone may develop between Dec. 16 and 22 – Pagasa MOST READ China’s acts of war in West PH Sea accelerating ecological ruin COA told: Release info on Office of the President’s secret funds Rufa Mae Quinto’s lawyer goes cryptic amid actress’ rumored marital woes After UAAP disappointment, Ateneo recruitment begins Follow @FMangosingINQ on Twitter --> View comments